Related references
Note: Only part of the references are listed.Double Dissociation of Monoacylglycerol Lipase Inhibition and CB1 Antagonism in the Central Amygdala, Basolateral Amygdala, and the Interoceptive Insular Cortex on the Affective Properties of Acute Naloxone-Precipitated Morphine Withdrawal in Rats
Kiri L. Wills et al.
NEUROPSYCHOPHARMACOLOGY (2016)
CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens
Marzieh Molaei et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2016)
The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence
Mohaddeseh Sadat Alavi et al.
PHARMACOLOGICAL REPORTS (2016)
Combined Treatment with Morphine and Δ9-Tetrahydrocannabinol in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal
L. R. Gerak et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice
Thomas F. Gamage et al.
DRUG AND ALCOHOL DEPENDENCE (2015)
Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey
A. R. Wilson-Poe et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in rats
Kiri L. Wills et al.
PSYCHOPHARMACOLOGY (2014)
Dual Inhibition of Endocannabinoid Catabolic Enzymes Produces Enhanced Antiwithdrawal Effects in Morphine-Dependent Mice
Divya Ramesh et al.
NEUROPSYCHOPHARMACOLOGY (2013)
CANNABINOID AND OPIOID INTERACTIONS: IMPLICATIONS FOR OPIATE DEPENDENCE AND WITHDRAWAL
J. L. Scavone et al.
NEUROSCIENCE (2013)
DISTRIBUTION OF CB1 CANNABINOID RECEPTORS AND THEIR RELATIONSHIP WITH MU-OPIOID RECEPTORS IN THE RAT PERIAQUEDUCTAL GRAY
A. R. Wilson-Poe et al.
NEUROSCIENCE (2012)
Behavioral effects of fatty acid amide hydrolase inhibition on morphine withdrawal symptoms
Siamak Shahidi et al.
BRAIN RESEARCH BULLETIN (2011)
Blockade of Endocannabinoid Hydrolytic Enzymes Attenuates Precipitated Opioid Withdrawal Symptoms in Mice
Divya Ramesh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors
Jillian L. Scavone et al.
BRAIN RESEARCH (2010)
Cellular Mechanisms Underlying the Interaction between Cannabinoid and Opioid System
D. Parolaro et al.
CURRENT DRUG TARGETS (2010)
Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system
Joel E. Schlosburg et al.
NATURE NEUROSCIENCE (2010)
Cannabinoid-1 Receptor Gene Deletion Has a Compartment-Specific Affect on the Dendritic and Axonal Availability of μ-Opioid Receptors and on Dopamine Axons in the Mouse Nucleus Accumbens
Diane A. Lane et al.
SYNAPSE (2010)
Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression
Fabricio A. Moreira et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Opioid dependence treatment: options in pharmacotherapy
Angela L. Stotts et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Cannabidiol, a Nonpsychotropic Component of Cannabis, Inhibits Cue-Induced Heroin Seeking and Normalizes Discrete Mesolimbic Neuronal Disturbances
Yanhua Ren et al.
JOURNAL OF NEUROSCIENCE (2009)
Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects
Jonathan Z. Long et al.
NATURE CHEMICAL BIOLOGY (2009)
Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties
Jack Bergman et al.
PHYSIOLOGY & BEHAVIOR (2008)
The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats
Kelly S. Sink et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2
Liana Fattore et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Spinal modulation of calcitonin gene-related peptide by endocannabinoids in the development of opioid physical dependence
Tuan Trang et al.
PAIN (2006)
Interactions between CB1 cannabinoid and μ opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core
A. N. M. Schoffelmeer et al.
NEUROPHARMACOLOGY (2006)
Adenosine A2a blockade prevents synergy between μ-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats
Lina Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Behavioural assessment of drug reinforcement and addictive features in rodents: an overview
Carles Sanchis-Segura et al.
ADDICTION BIOLOGY (2006)
Repeated exposure to Δ9-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity
ME Singh et al.
NEUROPHARMACOLOGY (2005)
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems
D Viganò et al.
PSYCHOPHARMACOLOGY (2005)
κ- and δ-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1 receptor knockout mice
L Urigüen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats
L Stinus et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Repeated administration with Δ9-tetrahydrocannabinol regulates μ-opioid receptor density in the rat brain
J Corchero et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716
ME Singh et al.
NEUROPHARMACOLOGY (2004)
Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens
VM Pickel et al.
NEUROSCIENCE (2004)
β-Endorphin elevations in the ventral tegmental area regulate the discriminative effects of Δ-9-tetrahydrocannabinol
M Solinas et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal
MR Azar et al.
PSYCHOPHARMACOLOGY (2003)
Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral Δ9-tetrahydrocannabinol
DL Cichewicz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Regional differences in naloxone modulation of Δ9-THC induced Fos expression in rat brain
KV Allen et al.
NEUROPHARMACOLOGY (2003)
Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404
I Del Arco et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice:: correlation with behaviour
M Maccarrone et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB1 receptor binding and mRNA levels
S Gonzalez et al.
DRUG AND ALCOHOL DEPENDENCE (2002)
Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice
TU Yamaguchi et al.
BRAIN RESEARCH (2001)
Δ9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins:: reduction in morphine withdrawal syndrome without change in rewarding effect
O Valverde et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
Reduction of opioid dependence by the CB1 antagonist SR141716A in mice:: evaluation of the interest in pharmacotherapy of opioid addiction
M Mas-Nieto et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice
M Martin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome
T Rubino et al.
LIFE SCIENCES (2000)
Share Paper
